Mary E. Godwin's Net Worth
$1.38 Million
Who is Mary E. Godwin?
Mary E. Godwin has an estimated net worth of $1.38 Million. This is based on reported shares across multiple companies, which include Isilon Systems, Inc., and Nautilus Biotechnology, Inc..
SEC CIK
Mary E. Godwin's CIK is 0001439716
Past Insider Trading and Trends
2010 was Mary E. Godwin's most active year for acquiring shares with 18 total transactions. Mary E. Godwin's most active month to acquire stocks was the month of July. 2010 was Mary E. Godwin's most active year for disposing of shares, totalling 31 transactions. Mary E. Godwin's most active month to dispose stocks was the month of August. 2010 saw Mary E. Godwin paying a total of $335,868.60 for 199,360 shares, this is the most they've acquired in one year. In 2010 Mary E. Godwin cashed out on 525,368 shares for a total of $1,712,654.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Isilon Systems, Inc. No price found
VP Operations
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.82K |
$33.85 | -$230,755.45 |
0
|
Dec 17 - Dec 21
| |||
Form 4
|
—
|
0
|
$18.81 | -$139,724.40 | 6.6K |
Scheduled
|
Nov 24
| ||
Form 4
|
—
|
0
|
$14.72 | -$101,909.00 | 6.6K |
Scheduled
|
Nov 12
| ||
Form 4
|
—
|
0
|
$16.64 | -$119,366.40 | 6.6K |
Scheduled
|
Oct 25
| ||
Form 4
|
—
|
0
|
$14.53 | -$99,616.80 | 6.6K |
Scheduled
|
Oct 12
| ||
Form 4
|
—
|
0
|
$13.84 | -$93,205.20 | 6.6K |
Scheduled
|
Sep 24
| ||
Form 4
|
—
|
0
|
$13.53 | -$90,256.80 | 6.6K |
Scheduled
|
Sep 13
| ||
Form 4
|
—
|
0
|
$11.78 | -$73,923.60 | 6.6K |
Scheduled
|
Aug 24
| ||
Form 4
| -10.70% | -791.00 |
$17.50 | -$13,842.50 | 6.6K |
Scheduled
|
Aug 18
| ||
Form 4
|
—
|
0
|
$8.43 | -$58,613.50 | 6.6K |
May 18
| |||
Form 4
|
—
|
0
|
$9.34 | -$355,572.00 | 6.6K |
Apr 26
| |||
Form 4
|
∞
| 6.6K |
—
|
—
| 6.6K |
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Nautilus Biotechnology, Inc. (NAUT) Snapshot price: $2.55
Senior VP, Operations
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$1.66 | -$83,769.00 |
0
|
Sep 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||